GLP-1
How GLP-1 Drugs Are Transforming America’s Taste Buds: Insights from IFF on Changing Food Preferences
Eighty-five percent of people using GLP-1 medications in the U.S. are changing what they eat and drink, according to a ... Read more
NC State Health Plan Considering Legal Action Against CVS Caremark: What You Need to Know
Negotiations between North Carolina’s State Health Plan and CVS Caremark, its pharmacy benefit manager (PBM), have hit a major snag. ... Read more
Essential Nutrition Support Guidelines for GLP-1 Obesity Therapies: Insights from Top Health Organizations
Four key organizations—American College of Lifestyle Medicine, American Society for Nutrition, Obesity Medicine Association, and The Obesity Society—recently collaborated on ... Read more
Unlocking Better Mental and Metabolic Health: How GLP-1 Receptor Agonists Transform Lives for Adults with Mental Illness
Recent research reveals that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may significantly aid in weight loss and enhance blood sugar ... Read more
Unveiling the Connection: How GLP-1 Drugs Can Reduce Brain Inflammation but Elevate Depression Risk
GLP-1 receptor agonists (GLP-1 RAs) are medications commonly used to manage type 2 diabetes and obesity. Initially, drugs like Ozempic ... Read more
Unlocking the Brain Benefits of GLP-1 Drugs: Are There Hidden Health Risks? – Insights from Neuroscience News
Summary: A recent study of over 2 million veterans shows that GLP-1 receptor agonists, like Ozempic and Wegovy, can provide ... Read more
